Epedigree Software Market to grow by USD 4023.9 million between 2024-2028
According to a research report “ Epedigree Software Market” by Deployment (On-premises, Cloud) End-user (Large enterprise, Small and medium enterprises) Geography (North America, Europe, APAC, South America, Middle East and Africa)- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 4023.9 million at a CAGR of 18.69% during the forecast period. In the pharmaceutical sector, the issue of drug counterfeiting represents a significant challenge. With the rise of Internet sales, inefficient supply chains, and lax regulations, this global concern is worth billions of dollars, with India and China serving as major manufacturing hubs. The proliferation of counterfeit drugs poses serious public safety risks and erodes consumer trust, negatively impacting the reputation of the entire industry. In response, Epedigree software solutions offer a robust response, ensuring product authenticity, supply chain security, and regulatory compliance..
Browse market data tables, figures, and in-depth TOC on “Epedigree Software Market” by Deployment (On-premises, Cloud) End-user (Large enterprise, Small and medium enterprises) Geography (North America, Europe, APAC, South America, Middle East and Africa) Global Forecast to 2028.
View detailed Table of Content- Click here
By Deployment, the On-premises segment is projected to dominate the market size in 2024.
In the enterprise sector, the adoption of ePedigree software has become prevalent, particularly among large businesses in IT and pharmaceuticals. The necessity for cloud-based solutions increases as these companies require remote assistance from global clients. ePedigree software's clientless functionality is invaluable in the pharmaceutical industry, enabling engineers to provide efficient remote support and multitask for swift problem resolution. Technicians can join support sessions from anywhere in the world using their cell phones, addressing customer or staff issues on a global scale.
By End-user, Large enterprise segment is expected to hold the largest market size for the year 2024.
In the ePedigree software market, on-premises deployment remains a preferred choice for businesses, particularly those in regulated industries. This approach grants organizations greater control over their data security and regulatory compliance. Additionally, on-premises deployment offers increased flexibility for customization and system integration. These factors contribute significantly to the enduring appeal of on-premises ePedigree solutions.
North America is forecasted to hold the largest market size by region in 2024.
In the business realm, Ephedigree Software Market signifies a significant sector, characterized by the production, distribution, and implementation of software solutions. Companies invest substantially in this market to streamline operations, enhance productivity, and gain a competitive edge. Key players in this industry leverage advanced technologies and innovative strategies to cater to evolving customer needs and stay ahead of the competition.
The Epedigree Software Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
In the dynamic and complex pharma supply chain industry, the implementation of advanced technologies such as cloud-based solutions, machine learning, and Internet of Things (IoT) has become essential for ensuring patient safety and combating counterfeiting. One such technology gaining significant traction is Epedigree software. This advanced solution leverages blockchain technology for serializability and ePedigree to ensure drug pedigree and authenticity. Epedigree software plays a crucial role in the pharmaceutical industry by providing a secure and transparent system for tracking and managing the supply chain of pharmaceutical products. It utilizes advanced analytics and smart devices to monitor and authenticate drugs, reducing the risk of contaminated medicine or counterfeit drugs entering the market. The market for Epedigree software is expected to grow significantly due to the increasing demand for drug serialization and the need for a more secure and efficient pharma supply chain. The use of barcodes and serial numbers in conjunction with cloud computing and machine learning algorithms enables real-time monitoring and analysis of the pharmaceutical product lifecycle, ensuring the highest level of patient safety and drug authenticity.
Market Research Overview
The Epedigree software market is experiencing significant growth in the digital healthcare sector, particularly in the pharmaceutical industry. This software plays a crucial role in track-and-trace solutions for healthcare IT investments in various sectors, including cosmetics, food and beverage, medical devices, and biotechnology firms. Epedigree software ensures flexibility and scalability in IT resources by utilizing advanced technologies such as blockchain, Internet of Things, Machine learning, Serialization, and Pharmaceutical Drug pedigree. The software is essential for patient safety and drug safety, reducing healthcare expenditures by minimizing wastage of products and optimizing inventory maintenance and stock management. Epedigree software also combats counterfeiting and contaminated medicine by ensuring the authenticity and serializability of pharmaceutical products. Cloud-based and on-premises solutions are available for Epedigree software, allowing for customization based on specific business needs. The software integrates with various smart devices and uses advanced analytics and big data to improve supply chain management and drug authentication processes. Virtual reality (VR), augmented reality (AR), and virtual assistants are also being explored to enhance the functionality and user experience of Epedigree software.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
